Straits Research released its highly anticipated report, “Healthcare Third-Party Logistics (3PL) Market Size & Outlook, 2026-2034.” According to the study, the market size is valued at USD 278.79 billion in 2025 and is projected to expand to USD 542.53 billion by 2034, registering a compound annual growth rate (CAGR) of 7.72%.

Market Dynamics

The growth of the global healthcare third-party logistics (3PL) market is driven by the increasing complexity of global healthcare supply chains, rising demand for biopharmaceuticals, vaccines, and temperature-sensitive products, and the growing trend of outsourcing logistics operations by pharmaceutical and medical device manufacturers to improve efficiency, scalability, and regulatory compliance. However, the market faces restraints such as high operational costs associated with cold chain management, stringent regulatory requirements, and limited standardization across global logistics networks, which can hinder seamless integration and increase the risk of noncompliance. Nevertheless, significant opportunities lie in the adoption of digital logistics technologies, including IoT-enabled tracking systems, AI-driven predictive analytics, and blockchain for transparency, as well as the expansion of healthcare infrastructure in emerging economies, which is expected to create new avenues for 3PL providers to deliver value-added, technology-driven logistics solutions.

Market Highlights

• Product: The biopharmaceuticals segment dominated the market in 2025 with a revenue share of 51.27%.
• Service: The warehousing & storage dominated the market in 2025, with a revenue share of 48.16%.
• Supply Chain: The cold chain segment is anticipated to register the fastest CAGR of 8.82%.
• Regional Insights: North America dominates the market with 37% share, driven by the strong presence of established pharmaceutical and biotechnology companies, advanced healthcare infrastructure, and high adoption of digital logistics technologies.